Data / Form D filings / SEVENTH SENSE BIOSYSTEMS, INC.
SEVENTH SENSE BIOSYSTEMS, INC.: Form D filings
SEVENTH SENSE BIOSYSTEMS, INC., a biotechnology company in Medford, MA, filed 18 Form D notices with the SEC between 2010 and 2018. The latest, on August 22, 2018, reports $18.5 million sold of a $20.5 million offering to 18 investors.
Find out what SEVENTH SENSE BIOSYSTEMS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 BOSTON AVENUE, SUITE 3700, Medford, MA, 02155
- Phone
- (617) 547-7246
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1451718
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2018 | New notice | $20,483,208 | $18,458,837 | $2,024,371 | 18 | Aug 9, 2018 | sec.gov |
| Feb 21, 2018 | New notice | $5,500,000 | $3,459,381 | $2,040,619 | 15 | Feb 6, 2018 | sec.gov |
| Sep 20, 2017 | New notice | $10,000,000 | $2,500,000 | $7,500,000 | 2 | Sep 6, 2017 | sec.gov |
| Nov 16, 2016 | New notice | $12,750,000 | $5,500,000 | $7,250,000 | 7 | Nov 7, 2016 | sec.gov |
| Dec 22, 2015 | New notice | $2,060,000 | $2,060,000 | $0 | 6 | Nov 25, 2015 | sec.gov |
| Aug 6, 2015 | Amendment | $16,287,084 | $14,287,084 | $2,000,000 | 8 | Jul 28, 2014 | sec.gov |
| Aug 8, 2014 | New notice | $16,467,084 | $10,467,084 | $6,000,000 | 8 | Jul 28, 2014 | sec.gov |
| Jun 18, 2014 | New notice | $450,000 | $450,000 | $0 | 5 | Jun 3, 2014 | sec.gov |
| Apr 10, 2014 | New notice | $930,000 | $930,000 | $0 | 5 | Mar 26, 2014 | sec.gov |
| Nov 21, 2013 | New notice | Indefinite | $360,000 | Indefinite | 5 | Nov 6, 2013 | sec.gov |
| Apr 1, 2013 | New notice | $157,500 | $157,500 | $0 | 1 | Mar 19, 2013 | sec.gov |
| Mar 18, 2013 | New notice | $1,800,000 | $1,800,000 | $0 | 5 | Mar 1, 2013 | sec.gov |
| Jun 19, 2012 | Amendment | $12,182,963 | $12,182,963 | $0 | 6 | Apr 25, 2011 | sec.gov |
| Jun 1, 2012 | New notice | $200,000 | $200,000 | $0 | 5 | May 17, 2012 | sec.gov |
| Apr 10, 2012 | New notice | $750,000 | $750,000 | $0 | 5 | Mar 26, 2012 | sec.gov |
| May 10, 2011 | New notice | $12,182,962 | $6,682,964 | $5,499,998 | 6 | Apr 25, 2011 | sec.gov |
| Oct 14, 2010 | New notice | $2,100,000 | $2,100,000 | $0 | 6 | Oct 1, 2010 | sec.gov |
| Jun 4, 2010 | New notice | $1,500,000 | $1,500,000 | $0 | 6 | May 26, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| ROBERT LANGER | Director | |
| ALAN CRANE | Director | |
| MARC CEULEMANS | Director | |
| DONALD HARDISON | Director | |
| HARRY WILCOX | Executive Officer, Director | |
| STUART BLITZ | Executive Officer | |
| TIMOTHY RICHARDS | Executive Officer | |
| HOWARD WEISMAN | Director | |
| PETER HUTT | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Aug 20, 2018 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SEVENTH SENSE BIOSYSTEMS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.